Respiratory medicine · 2013
Incidence and outcomes of bepridil-induced interstitial pneumonia.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yamasaki Kei, Yatera Kazuhiro, Noguchi Shingo, Oda Keishi, Akata Kentarou, Nishida Chinatsu, Kawanami Toshinori, Kawanami Yukiko, Ishimoto Hiroshi, Ono Shiro, Wakuta Yukio, Mukae Hiroshi
Аннотация
BACKGROUND: The incidence of bepridil-induced pulmonary toxicity, such as interstitial pneumonia, is still unknown. The aim of the present study was to evaluate the incidence of bepridil-induced pulmonary toxicity.
METHODS AND RESULTS: A total of 253 patients treated with bepridil between January 2009 and January 2011 were retrospectively evaluated. Eight out of the 222 evaluable patients (male/female: 5/3, age range: 64-97 years, average age: 80.5 years, median age: 81.0 years) showed bepridil-induced pulmonary toxicity.
CONCLUSIONS: The incidence of bepridil-induced pulmonary toxicity was 3.60% in our study population.
METHODS AND RESULTS: A total of 253 patients treated with bepridil between January 2009 and January 2011 were retrospectively evaluated. Eight out of the 222 evaluable patients (male/female: 5/3, age range: 64-97 years, average age: 80.5 years, median age: 81.0 years) showed bepridil-induced pulmonary toxicity.
CONCLUSIONS: The incidence of bepridil-induced pulmonary toxicity was 3.60% in our study population.